Priority setting for new technologies in medicine: qualitative case study

Published on Nov 25, 2000in BMJ27.604
· DOI :10.1136/bmj.321.7272.1316
Peter Singer79
Estimated H-index: 79
Douglas K. Martin38
Estimated H-index: 38
+ 1 AuthorsLaura M. Purdy6
Estimated H-index: 6
Objective To describe priority setting for new technologies in medicine. Design Qualitative study using case studies and grounded theory. Setting Two committees advising on priorities for new technologies in cancer and cardiac care in Ontario, Canada. Participants The two committees and their 26 members. Main outcome measures Accounts of priority setting decision making gathered by reviewing documents. interviewing members, and observing meetings. Results Six interrelated domains were identified for priority setting for new technologies in medicine: the institutions in which the decision are made, the people who make the decisions, the factors they consider, the reasons for the decisions, the process of decision making, and the appeals mechanism for challenging the decisions. Conclusion These domains constitute a model of priority setting for new technologies in medicine. The next step will be to harmonise this description of how priority setting decisions are made with ethical accounts of how they should be made.
  • References (17)
  • Citations (130)
📖 Papers frequently viewed together
200159.10The Lancet
101 Citations
413 Citations
1 Author (Norman Daniels)
402 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
Four years ago the case of Jaymee Bowen, more commonly known as Child B, captured the newspaper headlines. The coming together of a father who was determined to seek the treatment he believed was best for his daughter, doctors who disagreed about what treatment was appropriate, health service managers who were prepared to take a stand on the use of resources on services of questionable effectiveness, lawyers willing to test the decision of the health authority in the courts, and journalists who ...
50 CitationsSource
Abstract Objectives: To explore barriers to patients being referred for possible revascularisation. Design: Qualitative study using semi-structured interviews. Participants: 16 patients aged under 75 years with stable angina and their doctors. Setting: General practice in Toxteth, Liverpool. Results: Fear of both hospitals and medical tests was common and largely hidden from the doctors. Patients felt they were old, had low expectations of treatment, viewed angina as a chronic illness, and knew ...
97 CitationsSource
#1Robbie FoyH-Index: 29
#2June SoH-Index: 2
Last. J Howard ScarffeH-Index: 2
view all 4 authors...
The provision of high quality cancer services is a major priority for the NHS.1 However, greater budgetary pressures are being placed on specialist hospitals and health authorities by several factors: Christie Hospital NHS Trust in Manchester provides specialist cancer care to a population of 4.5million people from North Wales to Cumbria. The trust's drug budget of £4 million accounted for 18% of the total income from patient services in 1996-7,creating an obvious focus for annual negotiations w...
41 CitationsSource
#1Tony HopeH-Index: 15
#2Nicholas HicksH-Index: 6
Last. Sian M. GriffithsH-Index: 34
view all 5 authors...
Most governments would like to pretend that health care rationing does not exist. Those working in the NHS know that it does. There is simply not enough money for all patients to receive the best treatment.1 A few governments—the Netherlands, New Zealand, and Sweden, in particular—have grasped the nettle.2–4 In the United Kingdom, major decisions about what to fund or, more critically, what not to fund have been made at local level by health authorities, fundholding general practices, and, under...
51 CitationsSource
Education and debate pp 1000-7 The second international conference on priorities in health care, held in London this week, is important for two reasons. Firstly, it provides a reminder that the phenomenon of rationing is indeed international and not just a byproduct of the way Britain's National Health Service is designed or funded. Countries with very different healthcare systems and levels of healthcare spending are all grappling with the problem of how to reconcile growing demands and constra...
60 CitationsSource
#1S⊘ren HolmH-Index: 1
#2James E. SabinH-Index: 24
Last. Avi IsraeliH-Index: 14
view all 6 authors...
# The second phase of priority setting {#article-title-2} Editorial by Klein This article was presented at the second international conference on priorities in health care in London on 8-10 October 1998 This week sees the second international conference on priorities in health care in London. To mark the occasion we are publishing three of the papers that will be presented at the conference. Each illustrates, in a different way, how thinking about priority setting in health care has developed ov...
106 CitationsSource
What follows is the description of an improved hydraulic apparatus for the automatic adjustment of the inclination of the headlights of a motor vehicle, the adjustment being a dependent function of the axle load. The apparatus has a level sensor at each axle and each level sensor contains one metering piston and two positioning pistons. The rear axle level sensor is connected via two separate hydraulic lines to the front axle sensor, and the front axle sensor is in turn connected via two separat...
100 Citations
PROLOGUE: No country in the world can afford all of the medical care that providers can render to populations. Thus, in every nation governments and private-sector organizations design mechanisms that ration resources in ways that seem compatible with the values of a particular society. For the most part, governments establish these mechanisms, and most of the resources flow through public budgets or at least publicly fashioned funding channels. But in the United States the purchasers of medical...
219 CitationsSource
The most difficult and explosive responsibility for any health care system is deciding whether patients with life-threatening illnesses will receive insurance coverage for unproven treatments that they believe may make the difference between life and death. Potentially life-saving treatments with proven efficacy and safety (proven net benefit) and quack treatments for which there is no scientific rationale rarely pose major problems about insurance coverage. In a country as wealthy as the United...
51 CitationsSource
16 CitationsSource
Cited By130
#1Selena Knight ('KCL': King's College London)H-Index: 3
#2Benedict Hayhoe (Imperial College London)H-Index: 7
Last. Andrew Papanikitas (University of Oxford)H-Index: 5
view all 6 authors...
Background Clinical commissioning involves ethically challenging decisions about health resource allocation. However, commissioners come from a range of professional backgrounds with varying levels of training and expertise in ethical decision-making. Hence, they may lack the relevant training and resources to feel fully prepared for this increasingly demanding role. Aim This study aims to provide insight into how prepared commissioners feel in making ethical decisions; what ethics learning need...
#1Gregory Merlo (QUT: Queensland University of Technology)H-Index: 4
#2Katie Page (QUT: Queensland University of Technology)H-Index: 13
Last. Nicholas Graves (QUT: Queensland University of Technology)H-Index: 40
view all 4 authors...
Background and Objective There is a need for the application of theory in understanding the use of evidence from economic evaluations in healthcare decision making. The purpose of this study is to review the published literature on the use of evidence from economic evaluations for healthcare decision making and to map the findings to the Consolidated Framework for Implementation Research (CFIR).
#1Siun Gallagher (USYD: University of Sydney)H-Index: 2
#2Miles Little (USYD: University of Sydney)H-Index: 18
Abstract In this study we describe, synthesise, and discuss the experiences and views of doctors who participate as technical experts in health care priority setting, reflect on the ethical significance of the challenges to procedural and distributive justice they encounter, and propose an empirically derived practical approach to improving the fairness of the process. Between August 2015 and July 2016 we conducted semi-structured face-to-face interviews with 20 doctors in NSW, Australia, purpos...
#1S Hendriks (UvA: University of Amsterdam)H-Index: 5
#2Rens Vliegenthart (UvA: University of Amsterdam)H-Index: 33
Last. E.A.F. Dancet (Katholieke Universiteit Leuven)H-Index: 8
view all 4 authors...
STUDY QUESTION: Do gynaecologists, infertile patients and the general public, consider that regulation of the clinical implementation of stem cell-based fertility treatments is required? SUMMARY ANSWER: There is broad support from gynaecologists, patients and the general public for regulating the clinical implementation of future stem cell-based fertility treatments. WHAT IS KNOWN ALREADY: There is debate on the need to regulate the clinical implementation of novel techniques. Regulation may hin...
2 CitationsSource
#1Tineke Kleinhout-Vliek (EUR: Erasmus University Rotterdam)H-Index: 1
#2Antoinette de Bont (EUR: Erasmus University Rotterdam)H-Index: 18
Last. Bert Boer (EUR: Erasmus University Rotterdam)H-Index: 3
view all 3 authors...
Policy makers and insurance companies decide on coverage of care by both calculating (cost-) effectiveness and assessing the necessity of coverage.
2 CitationsSource
#1W. Dominika Wranik (Dal: Dalhousie University)H-Index: 3
#2Liesl Gambold (Dal: Dalhousie University)H-Index: 3
Last. Adrian R. Levy (Dal: Dalhousie University)H-Index: 40
view all 4 authors...
Summary Public reimbursement of drugs is a costly proposition for health care systems. Decisions to add drugs to the public formulary are often guided by review processes and committees. The evolution of the formulary review process in Canada's publicly funded health system is characterized by increased centralization and systematization. In the past, the review of evidence and recommendation was conducted at the regional level, but was replaced with the pan-Canadian Oncology Drug Review in 2011...
5 CitationsSource
#1Tatjana E. MacLeod (Monash University)H-Index: 1
#2Anthony Harris (Monash University)H-Index: 45
Last. Ajay MahalH-Index: 28
view all 3 authors...
Background The growing focus on patient-centred care has encouraged the inclusion of patient and public input into payer drug reimbursement decisions. Yet, little is known about patient/public priorities for funding high-cost medicines, and how they compare to payer priorities applied in public funding decisions for new cancer drugs.
15 CitationsSource
Three sets of issues tend to be overlooked in public health emergency preparedness and response, which can be addressed with new training protocols. The first issue is procedural and concerns the often intuitive (as opposed to deliberative) nature of effective crisis decision-making. The second issue is substantive and pertains to the incorporation and prioritization of ethical, political, and logistical concerns in public health emergency guidelines. The third issue is affective and concerns hu...
#1Mohammadreza Mobinizadeh (IAU: Islamic Azad University)H-Index: 5
#2Pouran Raeissi (IUMS: Iran University of Medical Sciences)H-Index: 6
Last. Seyed Jamaleddin Tabibi (IAU: Islamic Azad University)H-Index: 3
view all 5 authors...
Background: In the recent years, using health technologies to diagnose and treat diseases has had a considerable and accelerated growth. The proper use of these technologies may considerably help in the diagnosis and treatment of different diseases. On the other hand, unlimited and unrestricted entry of these technologies may result in induced demand by service providers. The aim of this study was to determine the appropriate criteria used in health technologies priority-setting models in the wo...
5 Citations
#1Mark TomlinsonH-Index: 47
#2Micky ChopraH-Index: 1
Last. Igor RudanH-Index: 112
view all 4 authors...
Background: It is estimated that more than $130 billion is invested globally into health research each year. Increasingly, there is a need to set priorities in health research investments in a fair and legitimate way, using a sound and transparent methodology. In this paper we review selected priority setting processes at national level in low and middle income countries. We outline a set of criteria to assess the process of research priority setting and use these to describe and evaluate priori...